A
$ Value
$0
Shares
12,770
Price
$0
Filed
Nov 25
Insider
Name
Leaman John Harold
Title
—
CIK
0001586657
Roles
Director
Transaction Details
Transaction Date
2025-11-21
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
12,770
Footnotes
These options vest over three years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.
Filing Info
Leaman John Harold's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-08 | TRAW | A | $0 |
| 2025-12-12 | TRAW | A | $0 |
| 2025-12-12 | TRAW | A | $0 |
| 2025-11-21 | TRAW | A | $0 |
| 2025-10-01 | TRAW | A | $0 |
Other Insiders at TRAW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| STOVER JACK E | — | — | 2026-03-08 |
| CAUTREELS WERNER | — | — | 2026-03-08 |
| Leaman John Harold | — | — | 2026-03-08 |
|
Dukes Iain D.
Chief Executive Officer
|
— | — | 2026-03-08 |
| Shoemaker Mary Teresa | — | — | 2026-03-08 |
| Clarke Trafford | — | — | 2026-03-08 |
|
Savchuk Nikolay
Chief Operating Officer
|
— | — | 2026-03-08 |
|
Pauza Charles David
Chief Science Officer Virology
|
— | — | 2026-03-08 |
|
Redfield Robert
Chief Medical Officer
|
— | — | 2026-03-08 |
|
Parker Charles Nolan
Chief Financial Officer
|
— | — | 2026-03-08 |